Insider Trading Activity - Adjuvant Capital GP L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Adjuvant Capital GP L.P.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-01-16 Sale	2024-01-18 6:18 pm	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	100,000	$19.65	$1,965,000	2,373,500 (Indirect Direct)	View
2023-11-14 Sale	2023-11-16 6:59 pm	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	1,810	$16.15	$29,224	2,473,500 (Indirect Direct)	View
2023-09-29 Sale	2023-10-03 7:13 pm	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	104,773	$16.27	$1,704,513	2,475,310 (Indirect Direct)	View
2023-09-27 Sale	2023-09-29 5:41 pm	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	9,357	$16.11	$150,708	2,580,083 (Indirect Direct)	View
2023-09-13 Sale	2023-09-15 5:17 pm	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	400	$16	$6,400	2,589,440 (Indirect Direct)	View
2023-09-06 Sale	2023-09-08 4:59 pm	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	7,140	$16.03	$114,484	2,589,840 (Indirect Direct)	View
2023-08-23 Sale	2023-08-25 4:31 pm	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	400	$16	$6,400	2,596,980 (Indirect Direct)	View
2022-03-29 Purchase(A)	2022-06-24 4:51 pm	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	166,666	$15	$2,499,990	2,597,380 (Indirect Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2022-06-06 Other	2022-06-24 5:06 pm	N/A N/A	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	26,511	$15	2,650,402 (Direct)	View
2022-03-29 Conversion(A)	2022-06-24 4:51 pm	N/A N/A	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	2,430,714	$0	2,597,380 (Direct)	View
Ownership(A)	2022-06-24 4:48 pm	N/A N/A	AN2 Therapeutics Inc.	ANTX	Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner	0	$0	2,430,714 (Direct)	View

(A) Indicate amendment filing.

Insider Trading & Ownership - Adjuvant Capital GP L.P.